Herpes viruses reactivate in more than half of crew aboard Space Shuttle and International Space Station missions, according to NASA research published in Frontiers in Microbiology. While only a small proportion develop symptoms, virus reactivation rates increase with spaceflight duration and could present a significant health risk on missions to Mars and beyond.
NASA's rapid viral detection systems and ongoing treatment research are beginning to safeguard astronauts -- and immunocompromised patients on Earth, too.
"NASA astronauts endure weeks or even months exposed to microgravity and cosmic radiation - not to mention the extreme G forces of take-off and re-entry," says senior author Dr. Satish K. Mehta of KBR Wyle at the Johnson Space Center. "This physical challenge is compounded by more familiar stressors like social separation, confinement and an altered sleep-wake cycle."
To study the physiological impact of spaceflight, Mehta and colleagues analyze saliva, blood and urine samples collected from astronauts before, during and after spaceflight.
"During spaceflight there is a rise in secretion of stress hormones like cortisol and adrenaline, which are known to suppress the immune system. In keeping with this, we find that astronaut's immune cells - particularly those that normally suppress and eliminate viruses - become less effective during spaceflight and sometimes for up to 60 days after."
In the midst of this stress-induced amnesty on viral killing, dormant viruses reactivate and resurface.
"To date, 47 out of 89 (53%) astronauts on short space shuttle flights, and 14 out of 23 (61 percent) on longer ISS missions shed herpes viruses in their saliva or urine samples," reports Mehta. "These frequencies -- as well as the quantity -- of viral shedding are markedly higher than in samples from before or after flight, or from matched healthy controls."
Overall, four of the eight known human herpes viruses were detected. These include the varieties responsible for oral and genital herpes (HSV), chickenpox and shingles (VZV) -- which remain lifelong in our nerve cells -- as well as CMV and EBV, which take permanent but uneventful residence in our immune cells during childhood. CMV and EBV, are two viruses associated with causing different strains of mononucleosis or the "kissing disease."
So far, this viral shedding is typically asymptomatic.
"Only six astronauts developed any symptoms due to viral reactivation," says Mehta. "All were minor."
However, continued virus shedding post flight could endanger immunocompromised or uninfected contacts on Earth, like newborns.
"Infectious VZV and CMV were shed in body fluids up to 30 days following return from the International Space Station," says Mehta.
What's more, as we prepare for human deep-space missions beyond the moon and Mars, the risk that herpes virus reactivation poses to astronauts and their contacts could become more crucial.
"The magnitude, frequency and duration of viral shedding all increase with length of spaceflight."
Developing countermeasures to viral reactivation is essential to the success of these deep-space missions, argues Mehta. "The ideal countermeasure is vaccination for astronauts -- but this is so far available only against VZV. Trials of other herpes virus vaccines show little promise, so our present focus is on developing targeted treatment regimens for individuals suffering the consequences of viral reactivation. This research has tremendous clinical relevance for patients on Earth too. Already, our spaceflight-developed technologies for rapid viral detection in saliva have been employed in clinics and hospitals around the world."
Source: Frontiers
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.